[go: up one dir, main page]

SG11201705306UA - Cgrp antagonist peptides - Google Patents

Cgrp antagonist peptides

Info

Publication number
SG11201705306UA
SG11201705306UA SG11201705306UA SG11201705306UA SG11201705306UA SG 11201705306U A SG11201705306U A SG 11201705306UA SG 11201705306U A SG11201705306U A SG 11201705306UA SG 11201705306U A SG11201705306U A SG 11201705306UA SG 11201705306U A SG11201705306U A SG 11201705306UA
Authority
SG
Singapore
Prior art keywords
cgrp antagonist
antagonist peptides
peptides
cgrp
antagonist
Prior art date
Application number
SG11201705306UA
Inventor
Kazimierz Wisniewski
Guangcheng Jiang
Aleksandr K Rabinovich
Javier J Sueiras-Diaz
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of SG11201705306UA publication Critical patent/SG11201705306UA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
SG11201705306UA 2015-01-06 2016-01-06 Cgrp antagonist peptides SG11201705306UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562100371P 2015-01-06 2015-01-06
PCT/EP2016/050110 WO2016110499A1 (en) 2015-01-06 2016-01-06 Cgrp antagonist peptides

Publications (1)

Publication Number Publication Date
SG11201705306UA true SG11201705306UA (en) 2017-07-28

Family

ID=55071041

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201705306UA SG11201705306UA (en) 2015-01-06 2016-01-06 Cgrp antagonist peptides

Country Status (33)

Country Link
US (1) US9969775B2 (en)
EP (1) EP3242882B1 (en)
JP (1) JP6929227B2 (en)
KR (1) KR102713739B1 (en)
CN (1) CN107207567B (en)
AR (1) AR103499A1 (en)
AU (1) AU2016206059B2 (en)
BR (1) BR112017013413A2 (en)
CL (1) CL2017001761A1 (en)
CO (1) CO2017007940A2 (en)
DK (1) DK3242882T3 (en)
EA (1) EA032082B1 (en)
ES (1) ES2924410T3 (en)
HR (1) HRP20220941T1 (en)
HU (1) HUE059379T2 (en)
IL (1) IL252903B (en)
JO (1) JO3669B1 (en)
LT (1) LT3242882T (en)
MA (1) MA41311B1 (en)
MD (1) MD3242882T2 (en)
MX (1) MX387920B (en)
MY (1) MY196439A (en)
PH (1) PH12017501214A1 (en)
PL (1) PL3242882T3 (en)
PT (1) PT3242882T (en)
RS (1) RS63467B1 (en)
SA (1) SA517381865B1 (en)
SG (1) SG11201705306UA (en)
SI (1) SI3242882T1 (en)
TN (1) TN2017000248A1 (en)
TW (1) TWI717331B (en)
UA (1) UA121490C2 (en)
WO (1) WO2016110499A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021501784A (en) * 2017-11-06 2021-01-21 オークランド ユニサービシーズ リミティド Peptide complex CGRP receptor antagonist and its preparation method and usage method
EP4647082A1 (en) 2024-05-08 2025-11-12 NUVIE BIO, Inc. Pharmaceutical composition comprising a cgrp receptor antagonist for the treatment of acute migraine
WO2025202938A1 (en) 2024-03-26 2025-10-02 Nuvie Bio, Inc. Pharmaceutical composition comprising a cgrp receptor antagonist for the treatment of acute migraine

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6268474B1 (en) * 1998-04-30 2001-07-31 Creighton University Peptide antagonists of CGRP-receptor superfamily and methods of use
TW200533398A (en) 2004-03-29 2005-10-16 Bristol Myers Squibb Co Novel therapeutic agents for the treatment of migraine
US20060004185A1 (en) * 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
JP2008515895A (en) * 2004-10-07 2008-05-15 メルク エンド カムパニー インコーポレーテッド CGRP receptor antagonist
SG158191A1 (en) * 2005-01-17 2010-01-29 Jerini Ag C5a receptor antagonists
US7994325B2 (en) * 2005-03-14 2011-08-09 Merck Sharp & Dohme Corp. CGRP receptor antagonists
US8168592B2 (en) * 2005-10-21 2012-05-01 Amgen Inc. CGRP peptide antagonists and conjugates
DK3045182T3 (en) * 2005-11-14 2018-03-19 Teva Pharmaceuticals Int Gmbh ANTAGONIST ANTIBODIES AGAINST CALCITONIN GEN-RELATED PEPTIDE TO TREAT HEAT
TW200813019A (en) * 2006-06-13 2008-03-16 Vertex Pharma CGRP receptor antagonists
AU2013211929B2 (en) 2012-01-26 2016-05-26 Christopher J. Soares Peptide antagonists of the calcitonin CGRP family of peptide hormones and their use

Also Published As

Publication number Publication date
EP3242882B1 (en) 2022-05-04
KR102713739B1 (en) 2024-10-04
SI3242882T1 (en) 2022-09-30
KR20170102302A (en) 2017-09-08
JO3669B1 (en) 2020-08-27
HUE059379T2 (en) 2022-11-28
EA201791456A1 (en) 2018-01-31
TN2017000248A1 (en) 2018-10-19
PT3242882T (en) 2022-08-09
AU2016206059A1 (en) 2017-07-20
JP6929227B2 (en) 2021-09-01
MD3242882T2 (en) 2022-10-31
SA517381865B1 (en) 2021-09-15
EA032082B1 (en) 2019-04-30
EP3242882A1 (en) 2017-11-15
TW201630929A (en) 2016-09-01
LT3242882T (en) 2022-08-25
MX387920B (en) 2025-03-19
HRP20220941T1 (en) 2022-10-28
ES2924410T3 (en) 2022-10-06
CN107207567A (en) 2017-09-26
CA2973041A1 (en) 2016-07-14
MY196439A (en) 2023-04-11
AR103499A1 (en) 2017-05-17
PL3242882T3 (en) 2022-10-31
BR112017013413A2 (en) 2018-01-09
PH12017501214A1 (en) 2018-01-08
AU2016206059B2 (en) 2019-07-25
MA41311B1 (en) 2022-10-31
RS63467B1 (en) 2022-08-31
US20180002378A1 (en) 2018-01-04
MA41311A (en) 2017-11-14
NZ732771A (en) 2024-07-05
WO2016110499A1 (en) 2016-07-14
IL252903A0 (en) 2017-08-31
MX2017008893A (en) 2017-10-25
DK3242882T3 (en) 2022-08-08
US9969775B2 (en) 2018-05-15
UA121490C2 (en) 2020-06-10
CN107207567B (en) 2021-11-23
IL252903B (en) 2021-01-31
JP2018505213A (en) 2018-02-22
TWI717331B (en) 2021-02-01
CO2017007940A2 (en) 2017-10-31
CL2017001761A1 (en) 2018-01-26

Similar Documents

Publication Publication Date Title
IL258892B (en) Cgrp receptor antagonists
IL258893A (en) Cgrp receptor antagonists
ZA201800452B (en) Cgrp receptor antagonists
IL258894A (en) Cgrp receptor antagonists
GB201520539D0 (en) Peptides
GB201520543D0 (en) Peptides
GB201520536D0 (en) Peptides
IL252903A0 (en) Cgrp antagonist peptides
GB201506316D0 (en) Novel peptide
GB201520541D0 (en) Peptides
GB201520542D0 (en) Peptides
ZA201704249B (en) Cgrp antagonist peptides
HK1239678A1 (en) Cgrp antagonist peptides
ZA201807767B (en) Angiotensin-1-receptor antagonists
PT3464324T (en) Angiotensin-1-receptor antagonists
GB201520537D0 (en) Peptides
GB201520535D0 (en) Peptides
GB201520534D0 (en) Peptides
GB201520538D0 (en) Peptides
GB201519667D0 (en) Peptides
GB201518700D0 (en) Peptides
GB201506360D0 (en) Novel peptide
GB201513320D0 (en) Peptides
GB201502185D0 (en) Polypeptide detection